Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

5.720 +0.290 (+5.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts 
From OptimizeRx Corporation
Via GlobeNewswire
MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗
Via Chartmill
OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗
Via Chartmill
News headline image
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
Powered by OptimizeRx’s new programmatic infrastructure, collaboration expands access to premium point of care inventory for life sciences marketers 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx (OPRX) Q1 2026 Earnings Transcript ↗
OptimizeRx (OPRX) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
OptimizeRx Q1 Earnings Call Highlights ↗
OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life... 
Via MarketBeat
Topics Earnings
News headline image
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
Discover the top movers in Wednesday's pre-market session. ↗
Via Chartmill
News headline image
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Whetstone Capital Exits GitLab as Enterprises Rethink AI-Driven Software Development Tools ↗
Whetstone Capital Advisors has sold its stake in GitLab, a unified DevOps platform competing in the fast-changing market for AI-assisted coding and secure software delivery. As companies look at... 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
This cloud-based software provider serves organizations worldwide with modular tools for work management and collaboration. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectiveness 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37% 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year ↗
One luxury resale stock is quietly delivering its strongest growth in years — despite insiders taking some profits. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors ↗
One fund just walked away from BrightView — here’s what the numbers suggest long-term investors should really pay attention to. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Fund Added 415,000 Shares of a Software Stock Down 26% This Past Year ↗
One fast-growing software company just won a major vote of confidence — here’s what’s behind it. 
Via The Motley Fool
News headline image
This Fund Just Bought $6 Million in Plug Power Stock — Is a Turnaround in Sight? ↗
One formerly high-flying alternative energy stock just got a surprising vote of confidence — here’s what the latest numbers reveal. 
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
Whetstone Sells All Freshworks Shares ↗
The investment firm sold all of its shares in the AI firm. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
News headline image
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript ↗
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
OptimizeRx Corp (NASDAQ:OPRX) Shows High-Growth Momentum with Strong Technical Breakout ↗
OptimizeRx (OPRX) stock shows a powerful breakout setup, combining a strong technical uptrend with explosive earnings and sales growth momentum. 
Via Chartmill
News headline image
OptimizeRx Corp (NASDAQ:OPRX) Delivers Strong Q3 Beat and Raises Guidance ↗
OptimizeRx Q3 earnings crush estimates with strong revenue and profit growth. The healthcare tech firm also raises its full-year 2025 guidance. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.